EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Surface active derivatives of ricinoleic acid



Surface active derivatives of ricinoleic acid



Fette Seifen Anstrichmittel 87(7): 283-289



Studying the dependence of tenside properties on their constitution, often all the attention is paid to the hydrophilic end, whereas the hydrophobic end is of minor importance. Studies of tensides for many years, produced of special fatty acids, have shown that these have a significant influence on many tenside properties. That does not only regard the special tenside properties as e.g. foaming, washing, purifying and emulsifying but especially the dermatological and toxicological compatibility of these compounds. Ricinoleic acid or its soaps and triglycerides have been known for long as substances which are very well tolerated by skin. Partly they contain marked skin protection or skin preserving properties. It is therefore of significant interest in which way these properties can be transferred to synthetic tensides. This was investigated as well with anionic and non ionogenic derivatives of the ricinoleic acid as with amphoteric and kationic derivatives and led partly to surprising results.

(PDF 0-2 workdays service: $29.90)

Accession: 006546386

Download citation: RISBibTeXText



Related references

Studies in some pharmaceutically important fatty acid derivatives reduction of ricinoleic acid hydrazide chaulmoogric acid hydrazide and their phenyl derivatives. Indian Journal of Pharmaceutical Sciences 52(5): 217-219, 1990

Metabolism of ricinoleic acid into gamma-decalactone: beta-oxidation and long chain acyl intermediates of ricinoleic acid in the genus Sporidiobolus sp. Fems Microbiology Letters 188(1): 69-74, 2000

Metabolism of ricinoleic acid into gamma-decalactone: beta-oxidation and long chain fatty acyl intermediates of ricinoleic acid in the genus Sporidiobolus sp. FEMS microbiology letters, 188(1): 69-74, 2000

Synthesis and biological evaluation of ricinoleic acid-based lipoamino acid derivatives. Bioorganic & Medicinal Chemistry Letters 26(21): 5198-5202, 2016

Antioxidant, antiphospholipase derivatives of ricinoleic acid. Official Gazette of the United States Patent & Trademark Office Patents 1201(3): 2186, Aug 19, 1997

Antimicrobial activity of some ricinoleic and oleic acid derivatives. Jour Amer Oil Chem Soc 38(6): 321-324, 1961

Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review. Current Medicinal Chemistry 23(35): 4037-4056, 2016

QSAR studies of antibacterial ricinoleic acid derivatives. Khimiko Farmatsevticheskii Zhurnal 41(3): 16-21, 2007

Esters of danthron with ricinoleic acid its derivatives and similar acids. Archiv der Pharmazie (Weinheim) 312(5): 409-416, 1979

Ricinoleic acid stimulation of active anion secretion in colonic mucosa of the rat. Journal of Clinical Investigation 63(4): 743-749, 1979

Characteristic properties of cutting fluid additives derived from the derivatives of ricinoleic acid polymers. Journal of the American Oil Chemists' Society 71(9): 1003-1006, 1994

Surface active galacturonic acid derivatives. Official Gazette of the United States Patent & Trademark Office Patents 1204(3): 2250, Nov 18, 1997

Maximization of bioconversion of castor oil into ricinoleic acid by response surface methodology. Bioresource Technology 100(18): 4067-4073, 2009

Preparation and surface active properties of alpha-acyloxysuccinic acid derivatives from malic acid and fatty acids of crude rice bran oil. Grasas y Aceites 51(5): 340-347, Septiembre-Octubre, 2000

Ricinoleic acid, the active ingredient of castor oil, increases nitric oxide synthase activity in the rat ileum and colon. International Journal of Pharmacognosy 35(5): 364-370, 1997